Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

TAKEDA PHARMACEUTICAL COMPANY

Filed by MR. BRIAN KELLY.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$10,000.00
Expenses
Not reported
Registrant
MR. BRIAN KELLY
Filing UUID
ee2cbafa-7b39-4bbe-b829-461681923855
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Trade and tariffs

TAR · Tariff (miscellaneous tariff bills)

Government tariffs on drug imporatation.

TRD · Trade (domestic/foreign)

Trade/Tariffs on drug pricing and importation

TAX · Taxation/Internal Revenue Code

tax issues related to drugs and pricing

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.